Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Wani RA; Dar MA; Chandel RK

doi:10.2147/NDT.S85295

open access to scientific and medical research

Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Corrigendum

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Total article views		HTML views	PDF downloads	Totals
7,799	Dovepress*	7,279+	304	7,583
	PubMed Central*	520	193	713
	Totals	7,799	497	8,296
*Since 30 March 2015 +Since July 2016

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.